Prognostic Factors, Treatment, and Outcomes of Limited-Stage Diffuse Large B-Cell Lymphoma (DLBCL) in the Rituximab (R) Era

被引：0
|
作者：
Hiniker, S. M. [1 ]
Pollom, E. L. [1 ]
Khodadoust, M. S. [1 ]
Kozak, M. M. [1 ]
Advani, R. H. [1 ]
Hoppe, R. T. [1 ]
机构：
[1] Stanford Univ, Stanford, CA 94305 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2014年 / 90卷
关键词：
D O I：
10.1016/j.ijrobp.2014.05.1993
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3185
引用
收藏
页码：S677 / S678
页数：2
相关论文
共 50 条
  • [21] The Kyoto Prognostic Index for patients with diffuse large B-cell lymphoma in the rituximab era
    T Kobayashi
    J Kuroda
    I Yokota
    K Tanba
    T Fujino
    S Kuwahara
    R Isa
    J Yamaguchi
    E Kawata
    T Akaogi
    H Uchiyama
    H Kaneko
    N Uoshima
    Y Kobayashi
    S Teramukai
    M Taniwaki
    Blood Cancer Journal, 2016, 6 : e383 - e383
  • [22] Prognostic Significance of EBV Association in Diffuse Large B-Cell Lymphoma in the Rituximab Era
    Niitsu, Nozomi
    Takahashi, Naoki
    Yoshino, Tadashi
    Okamoto, Masataka
    Nakamura, Shigeo
    BLOOD, 2015, 126 (23)
  • [23] The Kyoto Prognostic Index for Patients with Diffuse Large B-Cell Lymphoma in the Rituximab Era
    Kobayashi, Tsutomu
    Kuroda, Junya
    Yokota, Isao
    Tanba, Kazuna
    Taki, Tomohiko
    Fujino, Takahiro
    Kuwahara, Saeko
    Isa, Reiko
    Yamaguchi, Junko
    Kawata, Eri
    Akaogi, Teruaki
    Uchiyama, Hitoji
    Kaneko, Hiroto
    Uoshima, Nobuhiko
    Kobayashi, Yutaka
    Teramukai, Satoshi
    Taniwaki, Masafumi
    BLOOD, 2015, 126 (23)
  • [24] Comparison of prognostic models for patients with diffuse large B-cell lymphoma in the rituximab era
    Huang, Yu-Chung
    Liu, Chun-Yu
    Lu, Hsueh-Ju
    Liu, Han-Tsung
    Hung, Man-Hsin
    Hong, Ying-Chung
    Hsiao, Liang-Tsai
    Gau, Jyh-Pyng
    Liu, Jin-Hwang
    Hsu, Hui-Chi
    Chiou, Tzeon-Jye
    Chen, Po-Min
    Tzeng, Cheng-Hwai
    Yu, Yuan-Bin
    ANNALS OF HEMATOLOGY, 2013, 92 (11) : 1513 - 1520
  • [25] Prognostic impact of extranodal involvement in diffuse large B-cell lymphoma in the rituximab era
    Takahashi, Hiroyuki
    Tomita, Naoto
    Yokoyama, Masahiro
    Tsunoda, Saburo
    Yano, Takahiro
    Murayama, Kayoko
    Hashimoto, Chizuko
    Tamura, Kazuo
    Sato, Kazuya
    Ishigatsubo, Yoshiaki
    CANCER, 2012, 118 (17) : 4166 - 4172
  • [26] Prognostic impact of immunohistochemical biomarkers in diffuse large B-cell lymphoma in the rituximab era
    Seki, Ritsuko
    Ohshima, Koichi
    Fujisaki, Tomoaki
    Uike, Naokuni
    Kawano, Fumio
    Gondo, Hisashi
    Makino, Shigeyoshi
    Eto, Tetsuya
    Moriuchi, Yukiyoshi
    Taguchi, Fumihiro
    Kamimura, Tomohiko
    Tsuda, Hiroyuki
    Ogawa, Ryosuke
    Shimoda, Kazuya
    Yamashita, Kiyoshi
    Suzuki, Keiko
    Suzushima, Hitoshi
    Tsukazaki, Kunihiro
    Higuchi, Masakazu
    Utsunomiya, Atae
    Iwahashi, Masahiro
    Imamura, Yutaka
    Tamura, Kazuo
    Suzumiya, Junji
    Yoshida, Minoru
    Abe, Yasunobu
    Matsumoto, Tadashi
    Okamura, Takashi
    CANCER SCIENCE, 2009, 100 (10): : 1842 - 1847
  • [27] The Kyoto Prognostic Index for patients with diffuse large B-cell lymphoma in the rituximab era
    Kobayashi, T.
    Kuroda, J.
    Yokota, I.
    Tanba, K.
    Fujino, T.
    Kuwahara, S.
    Isa, R.
    Yamaguchi, J.
    Kawata, E.
    Akaogi, T.
    Uchiyama, H.
    Kaneko, H.
    Uoshima, N.
    Kobayashi, Y.
    Teramukai, S.
    Taniwaki, M.
    BLOOD CANCER JOURNAL, 2016, 6 : e383 - e383
  • [28] Comparison of prognostic models for patients with diffuse large B-cell lymphoma in the rituximab era
    Yu-Chung Huang
    Chun-Yu Liu
    Hsueh-Ju Lu
    Han-Tsung Liu
    Man-Hsin Hung
    Ying-Chung Hong
    Liang-Tsai Hsiao
    Jyh-Pyng Gau
    Jin-Hwang Liu
    Hui-Chi Hsu
    Tzeon-Jye Chiou
    Po-Min Chen
    Cheng-Hwai Tzeng
    Yuan-Bin Yu
    Annals of Hematology, 2013, 92 : 1513 - 1520
  • [29] Prognostication of diffuse large B-cell lymphoma in the rituximab era
    Ninan, Mary J.
    Wadhwa, Punit D.
    Gupta, Pankaj
    LEUKEMIA & LYMPHOMA, 2011, 52 (03) : 360 - 373
  • [30] Prognostic factors and outcome in 306 patients with diffuse large B-cell lymphoma (DLBCL)
    Oyan, Basak
    Tekuzman, Gulten
    Barista, Ibrahim
    Ozisik, Yavuz
    kars, Ayse
    Turker, Alev
    Yalcin, Suayib
    Guler, Nilufer
    Koc, Yener
    Kansu, Emin
    ANNALS OF ONCOLOGY, 2004, 15 : 153 - 153
12345